Zetomipzomib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Zetomipzomib, covering 2025-12-05 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) [Phase 2]